UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MSR134 Optimizing Fractional Polynomials by Using Variable Powers

Value in health, 2022-12, Vol.25 (12), p.S376-S376

2022

Volltextzugriff (PDF)

POSA303 Influence of Treatment Effect on Parameters in Fractional Polynomials for Network Meta-Analyses

Value in health, 2022-01, Vol.25 (1), p.S198-S199

2022

Volltextzugriff (PDF)

HTA241 Health Equity and the Health Technology Assessment Process: Are Children and Young People Being Overlooked? A Review of Pediatric National Institute of Health and Care Excellence Technology Appraisals

Value in health, 2023-12, Vol.26 (12), p.S366

2023

Volltextzugriff (PDF)

EE204 Saving Lives through Early Access: Exploring the Impact of a Managed Access Agreement in Adjuvant EGFRm NSCLC

Value in health, 2023-12, Vol.26 (12), p.S90

2023

Volltextzugriff (PDF)

MSR130 Current Trends in Quantitative Bias Analysis for Unmeasured Confounders: A Targeted Literature Review

Value in health, 2023-12, Vol.26 (12), p.S418

2023

Volltextzugriff (PDF)

MSR83 Predicting Pseudo Individual Patient-Level Data with Covariates

Value in health, 2023-06, Vol.26 (6), p.S292-S293

2023

Volltextzugriff (PDF)

MSR139 Safe to Assume? Unpacking Regression Assumptions for Utility Data

Value in health, 2022-12, Vol.25 (12), p.S376-S376

2022

Volltextzugriff (PDF)

HPR4 ISPOR HEOR Trends Over Time: What Is the Influence of Macro HTA Changes?

Value in health, 2022-12, Vol.25 (12), p.S232-S232

2022

Volltextzugriff (PDF)

MSR64 Utility Analysis Methods: Can One Method Fit It All or Is a Case-By-Case Approach Required?

Value in health, 2022-12, Vol.25 (12), p.S362-S362

2022

Volltextzugriff (PDF)

MSR109 Can Jointly Modelling PFS and OS With Mixture Cure Models Overcome Data Immaturity Problems?

Value in health, 2022-12, Vol.25 (12), p.S371-S371

2022

Volltextzugriff (PDF)

EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

Value in health, 2024-06, Vol.27 (6), p.S115-S116

2024

Volltextzugriff (PDF)

Involved free light chain: an early independent predictor of response and progression in multiple myeloma

Leukemia & lymphoma, 2021-07, Vol.62 (9), p.2227-2234

2021

Volltextzugriff (PDF)

MS2 Methods to Optimise Survival Predictions Using Multistate Models in Oncology

Value in health, 2020-12, Vol.23, p.S405-S405

2020

Volltextzugriff (PDF)

EE266 Societal Economic Impact of Treatment with Adjuvant Osimertinib in Patients with Early-Stage (IB-IIIA) EGFRm NSCLC

Value in health, 2023-06, Vol.26 (6), p.S107-S107

2023

Volltextzugriff (PDF)

HTA40 Living Network Meta-Analysis for up-to-Date Comparative Effectiveness: A Case Study in Metastatic Castration Resistant Prostate Cancer (MCRPC)

Value in health, 2023-06, Vol.26 (6), p.S265-S265

2023

Volltextzugriff (PDF)

MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations

Value in health, 2022-12, Vol.25 (12), p.S359-S359

2022

Volltextzugriff (PDF)

HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM)

Value in health, 2022-12, Vol.25 (12), p.S302-S303

2022

Volltextzugriff (PDF)

HTA145 Living Network Meta-Analysis for Up-to-Date Comparative Effectiveness: A Case Study in Multiple Myeloma Maintenance

Value in health, 2022-12, Vol.25 (12), p.S325-S325

2022

Volltextzugriff (PDF)

POSC322 The Impact of Treatment Coefficient Parameterization for Mixture Cure Models on Cost-Effectiveness Models

Value in health, 2022-01, Vol.25 (1), p.S210-S210

2022

Volltextzugriff (PDF)

POSA428 The Impact of Treatment Effect Parameterization in Mixture Cure Models on Survival Estimates and Uncertainty

Value in health, 2022-01, Vol.25 (1), p.S273-S273

2022

Volltextzugriff (PDF)

POSC313 Network Meta-Interpolation; A Fast, Novel NMA Approach Accounting for Effect Modification

Value in health, 2022-01, Vol.25 (1), p.S209-S209

2022

Volltextzugriff (PDF)

MSR77 Bayesian Hierarchical Model-Based Network Meta-Analysis to Overcome Survival Extrapolation Challenges Caused by Immature Data: Application in Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) PD-L1>1

Value in health, 2022-12, Vol.25 (12), p.S364-S365

2022

Volltextzugriff (PDF)

NM1 A Comparison on Different Network-Meta Analysis (NMA) Models Using Randomized Clinical Trials (RCTS) in Transplant-Ineligible (TIE) NEWLY Diagnosed Multiple Myeloma (NDMM)

Value in health, 2020-12, Vol.23, p.S406-S406

2020

Volltextzugriff (PDF)

EX1 How to Select the Appropriate Survival Extrapolation Method? a Proposed Framework

Value in health, 2020-12, Vol.23, p.S401-S402

2020

Volltextzugriff (PDF)

P44 Novel and Existing Flexible Survival Methods for Network Meta-Analyses

Value in health, 2022-01, Vol.25 (1), p.S10-S10

2022

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(193)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(235)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

MSR134 Optimizing Fractional Polynomials by Using Variable Powers

POSA303 Influence of Treatment Effect on Parameters in Fractional Polynomials for Network Meta-Analyses

HTA241 Health Equity and the Health Technology Assessment Process: Are Children and Young People Being Overlooked? A Review of Pediatric National Institute of Health and Care Excellence Technology Appraisals

EE204 Saving Lives through Early Access: Exploring the Impact of a Managed Access Agreement in Adjuvant EGFRm NSCLC

MSR130 Current Trends in Quantitative Bias Analysis for Unmeasured Confounders: A Targeted Literature Review

MSR83 Predicting Pseudo Individual Patient-Level Data with Covariates

MSR139 Safe to Assume? Unpacking Regression Assumptions for Utility Data

HPR4 ISPOR HEOR Trends Over Time: What Is the Influence of Macro HTA Changes?

MSR64 Utility Analysis Methods: Can One Method Fit It All or Is a Case-By-Case Approach Required?

MSR109 Can Jointly Modelling PFS and OS With Mixture Cure Models Overcome Data Immaturity Problems?

EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

Involved free light chain: an early independent predictor of response and progression in multiple myeloma

MS2 Methods to Optimise Survival Predictions Using Multistate Models in Oncology

EE266 Societal Economic Impact of Treatment with Adjuvant Osimertinib in Patients with Early-Stage (IB-IIIA) EGFRm NSCLC

HTA40 Living Network Meta-Analysis for up-to-Date Comparative Effectiveness: A Case Study in Metastatic Castration Resistant Prostate Cancer (MCRPC)

MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations

HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM)

HTA145 Living Network Meta-Analysis for Up-to-Date Comparative Effectiveness: A Case Study in Multiple Myeloma Maintenance

POSC322 The Impact of Treatment Coefficient Parameterization for Mixture Cure Models on Cost-Effectiveness Models

POSA428 The Impact of Treatment Effect Parameterization in Mixture Cure Models on Survival Estimates and Uncertainty

POSC313 Network Meta-Interpolation; A Fast, Novel NMA Approach Accounting for Effect Modification

MSR77 Bayesian Hierarchical Model-Based Network Meta-Analysis to Overcome Survival Extrapolation Challenges Caused by Immature Data: Application in Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) PD-L1>1

NM1 A Comparison on Different Network-Meta Analysis (NMA) Models Using Randomized Clinical Trials (RCTS) in Transplant-Ineligible (TIE) NEWLY Diagnosed Multiple Myeloma (NDMM)

EX1 How to Select the Appropriate Survival Extrapolation Method? a Proposed Framework

P44 Novel and Existing Flexible Survival Methods for Network Meta-Analyses

Suchergebnisse filtern